Trial · NCT01977573
Results by group270
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 270
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Summary of Hemoglobin (Hgb) Concentration at Week 24 | rhEPO-Naive GSK1278863 | Original n=45,15,19,13 | 10.20 | Standard Deviation 0.906 | grams per deciliter |
| Summary of Hemoglobin (Hgb) Concentration at Week 24 | rhEPO-Naive Control | Original n=45,15,19,13 | 10.64 | Standard Deviation 0.664 | grams per deciliter |
| Summary of Hemoglobin (Hgb) Concentration at Week 24 | rhEPO-User GSK1278863 | Original n=45,15,19,13 | 10.03 | Standard Deviation 0.522 | grams per deciliter |
| Summary of Hemoglobin (Hgb) Concentration at Week 24 | rhEPO-User Control | Original n=45,15,19,13 | 10.66 | Standard Deviation 0.620 | grams per deciliter |
| Summary of Hemoglobin (Hgb) Concentration at Week 24 | rhEPO-Naive GSK1278863 | Amended n=61,21,11,17 | 10.96 | Standard Deviation 1.044 | grams per deciliter |
| Summary of Hemoglobin (Hgb) Concentration at Week 24 | rhEPO-Naive Control | Amended n=61,21,11,17 | 11.05 | Standard Deviation 1.144 | grams per deciliter |
| Summary of Hemoglobin (Hgb) Concentration at Week 24 | rhEPO-User GSK1278863 | Amended n=61,21,11,17 | 10.42 | Standard Deviation 0.827 | grams per deciliter |
| Summary of Hemoglobin (Hgb) Concentration at Week 24 | rhEPO-User Control | Amended n=61,21,11,17 | 10.86 | Standard Deviation 1.182 | grams per deciliter |
| Number of Participants With Hemoglobin (Hgb) in the Target Range at Week 24 | rhEPO-Naive GSK1278863 | 78 | participants | ||
| Number of Participants With Hemoglobin (Hgb) in the Target Range at Week 24 | rhEPO-Naive Control | 20 | participants | ||
| Number of Participants With Hemoglobin (Hgb) in the Target Range at Week 24 | rhEPO-User GSK1278863 | 22 | participants | ||
| Number of Participants With Hemoglobin (Hgb) in the Target Range at Week 24 | rhEPO-User Control | 19 | participants | ||
| Number of Participants Reaching Pre-defined Hgb Stopping Criteria | rhEPO-Naive GSK1278863 | 0 | Participants | ||
| Number of Participants Reaching Pre-defined Hgb Stopping Criteria | rhEPO-Naive Control | 0 | Participants | ||
| Number of Participants Reaching Pre-defined Hgb Stopping Criteria | rhEPO-User GSK1278863 | 0 | Participants | ||
| Number of Participants Reaching Pre-defined Hgb Stopping Criteria | rhEPO-User Control | 0 | Participants | ||
| Percent Change From Baseline in Hepcidin Concentration at Week 24 | rhEPO-Naive GSK1278863 | -19.27 | 95% Confidence Interval -28.10 to -9.36 | percent change in Hepcidin | |
| Percent Change From Baseline in Hepcidin Concentration at Week 24 | rhEPO-Naive Control | 6.67 | 95% Confidence Interval -13.62 to 31.72 | percent change in Hepcidin | |
| Percent Change From Baseline in Hepcidin Concentration at Week 24 | rhEPO-User GSK1278863 | -9.87 | 95% Confidence Interval -28.59 to 13.76 | percent change in Hepcidin | |
| Percent Change From Baseline in Hepcidin Concentration at Week 24 | rhEPO-User Control | -17.12 | 95% Confidence Interval -33.22 to 2.86 | percent change in Hepcidin |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01977573/results